Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Vandetanib successfully controls medullary thyroid cancer-related Cushing syndrome in an adolescent patient.
[cushing syndrome]
Ectopic
Cushing
syndrome
due
to
ACTH
secretion
from
metastatic
medullary
thyroid
cancer
(
MTC
)
is
associated
with
significant
morbidity
and
mortality
.
The
aim
of
the
study
was
to
describe
the
first
case
of
Cushing
syndrome
associated
with
MTC
in
a
pediatric
patient
and
the
successful
reversal
of
Cushing
syndrome
with
tyrosine
kinase
inhibitor
(
vandetanib
)
therapy
.
A
17
-
year
-old
Brazilian
adolescent
presented
with
metastatic
MTC
and
associated
ACTH-dependent
ectopic
Cushing
syndrome
in
the
context
of
multiple
endocrine
neoplasia
type
2
B
.
When
the
patient
was
treated
with
the
tyrosine
kinase
inhibitor
vandetanib
,
rapid
decrease
in
serum
cortisol
and
improvement
of
clinical
symptoms
were
observed
.
We
describe
the
first
pediatric
case
of
clinical
and
biochemical
improvement
of
paraneoplastic
MTC
-related
Cushing
syndrome
after
treatment
with
vandetanib
.
Vandetanib
and
possibly
other
tyrosine
kinase
inhibitors
may
be
a
novel
beneficial
option
in
patients
with
neuroendocrine
tumor
-related
ectopic
Cushing
syndrome
.
Diseases
Validation
Diseases presenting
"the successful reversal of cushing syndrome with tyrosine kinase inhibitor"
symptom
cushing syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom